President and COO of Adaptive Biotechnologies, Julie Rubinstein, sells shares worth $897,000.
President and COO of Adaptive Biotechnologies, Julie Rubinstein, sells shares worth $897,000.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in